Monthly Archives: May 2018

Weekly Roundup 5.25.18

Posted on May 25, 2018 by Mark Senak

It is Memorial Day Weekend!  The opening bell for summer vacations has arrived. It is time to do your wardrobe switch – get out the white shoes, sandals and linen clothing and put the corduroys away until Labor Day. Time … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5.25.18

Weekly Roundup 5.18.18

Posted on May 18, 2018 by Mark Senak

There has been so much rain in the past week, it is difficult for those of us in Washington, D.C. to remember that we live in that Washington and not Washington state. It has been relentless and it continues. It … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5.18.18

FDA and The Scarlet Letter

Posted on May 17, 2018 by Mark Senak

FDA apparently intends to implement today an idea that has been kicking around for a while to begin publishing the names of companies that have had letters of complaint lodged against them asserting that they are taking actions to block … Continue reading →

Posted in FDA Policy, Generic Drugs | 1 Comment

Weekly Roundup 5.11.18

Posted on May 11, 2018 by Mark Senak

Soon school will be out, rush hour will be less hectic, vacations long planned will be taken. Pollen counts are high and thunderstorms threaten to materialize nearly every other day. Washington is moving at high speed though the gravity of … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5.11.18

Pharma, FDA and Web Site Mobilization

Posted on May 10, 2018 by Mark Senak

In 2009 FDA set up the framework outlining its approach to regulating promotional speech by pharmaceutical companies by posing five questions for discussion during a two-day public meeting the agency held in Washington, D.C.  Rather than issue a single guidance … Continue reading →

Posted in New and Social Media, Social Media | Comments Off on Pharma, FDA and Web Site Mobilization